Atorvastatin Lactam Sodium Salt Impurity(CAS: 148217-40-7)

Atorvastatin Lactam Sodium Salt Impurity (CAS: 148217-40-7) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the EU, and FDA and EPA requirements in the USA. It is important to comply with local and international regulations regarding the handling, storage, and disposal of this compound.

In the synthesis of atorvastatin, alternatives to Atorvastatin Lactam Sodium Salt Impurity include using other impurity forms such as Atorvastatin Lactam or Atorvastatin Sodium. These alternatives can be chosen based on the specific requirements of the synthesis process, including cost, availability, and reactivity.

The market for Atorvastatin Lactam Sodium Salt Impurity (CAS: 148217-40-7) is driven by ongoing research into statin drugs and their impurity profiles. Recent trends show an increased focus on impurity analysis to ensure drug safety and efficacy. Additionally, there is growing interest in the development of more stringent regulatory standards for drug impurities, which impacts the demand for high-quality analytical reagents.

Waste containing Atorvastatin Lactam Sodium Salt Impurity (CAS: 148217-40-7) should be collected in appropriate containers and stored safely. Proper incineration or professional waste disposal services should be used to ensure environmental safety. It is crucial to follow local and international regulations for the disposal of hazardous materials, including the use of protective equipment and adherence to safety protocols.